State Government / Delaware / Legislation / HB 395
Source-provided summary
The General Assembly recognizes that Delaware’s industrial hemp farmers and processors play an important role in the State’s agricultural economy and that non-intoxicating industrial hemp products are lawful and should continue to be cultivated, produced, and sold in accordance with state and federal law. Nothing in this Act is intended to criminalize lawful industrial hemp or disrupt the legitimate industrial hemp industry. The General Assembly finds that an unregulated market for intoxicating THC consumable products has emerged in Delaware, notwithstanding prior legislation making clear that intoxicating products derived from the cannabis plant are marijuana and must be sold only in licensed, regulated establishments. Intoxicating consumable products containing high levels of THC are now widely available in retail outlets, many of which operate in and target our most vulnerable communities. These products are frequently sold without age restrictions, product testing, potency limits, or meaningful labeling, and are often marketed in ways that make them especially appealing and accessible to minors. This Act reaffirms Delaware’s commitment to a responsible adult-use marijuana industry by ensuring that all cannabis-related products sold in this State meet the highest standards of health and safety. To that end, the Act strengthens the requirement that consumable products containing a specified level of THC, regardless of their source, be sold only through licensed establishments and be subject to appropriate regulatory oversight. By ensuring these products are integrated into Delaware’s existing, comprehensive regulatory framework for adult-use marijuana—which includes stringent testing, labeling, packaging, and age-restriction requirements—this Act safeguards public health and prevents unregulated intoxicating THC consumable products from undermining the safety protections established for Delawareans, particularly children and adolescents.
Latest development · Jun 16, 2026
Assigned to Health & Social Services Committee in Senate
Civixly approval
No ratings yet
Not enough ratings yet. Public approval appears at 5+ ratings.
Civixly topics
Document type
Primary sponsors are listed before cosponsors and other sponsoring entities.
Newest action first. Action language is supplied by the state source.
Assigned to Health & Social Services Committee in Senate
Passed By House. Votes: 35 YES 4 NO 2 ABSENT
Amendment HA 1 to HB 395 - Passed In House by Voice Vote
Amendment HA 1 to HB 395 - Introduced and Placed With Bill
Reported Out of Committee (Health & Human Development) in House with 3 Favorable, 6 On Its Merits
Re-Assigned to Health & Human Development Committee in House
Introduced and Assigned to Economic Development/Banking/Insurance & Commerce Committee in House
0 comments across 0 threads
Loading comments...